Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Clinical trial NCT05654506 · RECRUITING
Trial details
- NCT number
- NCT05654506
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2026-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.